Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0233481 ANTI-CD25 ANTIBODIES AND THEIR USES
The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat...
2017/0233480 ANTI-VEGFR ANTIBODY AND USES THEREOF
The present invention relates to an antibody or antigen-binding fragment thereof that bind human vascular endothelial growth factor receptor 2 (VEGFR-2). The...
2017/0233479 ANTI-VISTA ANTIBODIES AND FRAGMENTS, USES THEREOF, AND METHODS OF IDENTIFYING SAME
The present invention relates to antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of eliciting certain...
2017/0233478 Antibodies Directed Against ICOS and Uses Thereof
The present invention provides antibodies directed against ICOS or a derivative thereof which neutralize ICOS engagement on Treg by inhibiting the fixation...
2017/0233477 CELL LINE 3M
The present invention provides, inter alia, an isolated cell line, 3M as well as methods for making such a cell line and methods of using such a cell line,...
2017/0233476 Antibody Therapeutics That Bind CTLA4
There is disclosed compositions and methods relating to or derived from anti-CTLA4 antibodies. More specifically, there is disclosed fully human antibodies...
2017/0233475 ANTIBODIES BINDING TO HUMAN AND CYNOMOLGUS CD3 EPSILON
One aspect as reported herein is using a method comprising the step of immunizing an experimental animal, three times with primary cynomolgus PBLs, whereby the...
2017/0233474 BINDING-TRIGGERED TRANSCRIPTIONAL SWITCHES AND METHODS OF USE THEREOF
The present disclosure provides binding-triggered transcriptional switch polypeptides, nucleic acids comprising nucleotide sequences encoding the ...
2017/0233473 C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of...
2017/0233472 ROR1-Binding Molecules, and Methods of Use Thereof
The present invention is directed to optimized ROR1-binding molecules having enhanced affinity and superior ability to mediate redirected cytotoxicity of tumor...
2017/0233471 ANTI-LGR5 ANTIBODIES AND USES THEREOF
The invention provides anti-LgR5 antibodies and methods of using the same.
2017/0233470 ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF
The present invention relates to a neutralising antibody which is capable of binding to neurotensin with high affinity. The antibody of the present invention...
2017/0233469 PROPHYLAXIS OF COLORECTAL AND GASTROINTESTINAL CANCER
The present disclosure provides methods and compositions useful for preventing gastrointestinal and/or colorectal cancer in animals, including humans, having...
2017/0233468 IL-17 ANTAGONIST ANTIBODIES
The disclosure relates to antibodies against human IL-17 which act as antagonists of IL-17, and their use in the diagnosis or treatment of IL-17 mediated...
2017/0233467 Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 for Ocular Therapies
The present disclosure provides methods of treating ocular disorders using anti-angiogenic antibodies and pharmaceutical formulations.
2017/0233466 Methods for Treating or Preventing Atherosclerosis by Administering an Inhibitor of ANGPTL3
The present invention provides methods and compositions for treating or preventing atherosclerosis in a subject. The methods of the present invention comprise...
2017/0233465 TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse...
2017/0233464 Use of TGF-Beta Antagonists to Treat Infants at Risk of Developing Bronchopulmonary Dysplasia
The disclosure relates to methods of treating an infant at risk of developing bronchopulmonary dysplasia, including premature infants, by administering a...
2017/0233463 Anti-Alpha Synuclein Binding Molecules
Provided are anti-human .alpha.-synuclein-specific binding molecules, e.g., antibodies or antiben-binding fragments, variants or derivatives thereof, as...
2017/0233462 Antibody Against Secreted N-Terminal Peptide of GPC3 Present in Blood or C-Terminal Peptide of GPC3
Disclosed is an antibody against a secreted form of GPC3 capable of detecting a secreted form of glypican 3 (GPC3) in a test sample. It is possible to...
2017/0233461 COMPOSITIONS AND METHODS FOR PHAGOCYTE DELIVERY OF ANTI-STAPHYLOCOCCAL AGENTS
The present application generally relates to multi-specific molecules that bind to multiple bacterial virulence factors, methods for producing these binding...
2017/0233460 Anti-Dengue Virus NS1 Protein Monoclonal Antibodies
The present invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample that...
2017/0233459 Systems and Methods for the Production of Human Polyclonal Antibodies
Disclosed herein is a method for producing human antibodies against a pathogen comprising injecting a non-human animal with a pathogen-derived DNA vaccine in...
2017/0233458 METHOD OF MANUFACTURING INTRAVENOUS IMMUNOGLOBULIN FROM FRACTION III
The present subject matter is directed to a method of manufacturing purified IVIG from Fraction III of plasma, comprising re-constituting a Fraction III paste...
2017/0233457 Immunoglobulin Variable Region Libraries
Antigen-specific immunoglobulin V-regions are identified from a library of nucleic acids amplified using polymerase chain reaction using leader ...
2017/0233456 AN IMPROVED EXPRESSION CASSETTE FOR PACKAGING AND EXPRESSION OF VARIANT FACTOR VIII FOR THE TREATMENT OF...
Factor VIII variants and methods of use thereof are disclosed. In particular embodiments, Factor VIII variants are expressed more efficiently by cells over...
2017/0233455 VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA A
The present disclosure provides, among other aspects, codon-altered polynucleotides encoding Factor VIII variants for expression in mammalian cells. In some...
2017/0233454 CHIMERIC ANTIGEN RECEPTOR CONTAINING A TOLL-LIKE RECEPTOR INTRACELLULAR DOMAIN
The present invention relates to a chimeric antigen receptor, a nucleic acid encoding the same and a cell expressing the same, and their use in manufacturing...
2017/0233453 METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS
Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian...
2017/0233452 CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO AVB6 INTEGRIN AND METHODS OF USE THEREOF TO TREAT CANCER
Disclosed are chimeric antigen receptors (CAR) specific to .alpha.v.beta.6 integrin which is uniquely expressed in a wide variety of cancers. Also disclosed...
2017/0233451 HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
High affinity PD-1 mimic polypeptides are provided, which (i) comprise at least one amino acid change relative to a wild-type PD-1 protein; and (ii) have an...
2017/0233450 VIRUS LIKE PARTICLE COMPRISING PD-1 ANTIGEN OR PD-1 LIGAND ANTIGEN
The present invention provides a virus like particle comprising a virus structural protein and an antigen derived from PD-1 or a ligand of PD-1, and a...
2017/0233449 FUSIONS OF ANTIBODIES TO CD38 AND ATTENUATED INTERFERON ALPHA
The present invention provides a polypeptide construct comprising a peptide or polypeptide signaling ligand linked to an antibody or antigen binding portion...
2017/0233448 INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE
Various methods and compositions are provided which can be employed to modulate the immune system. Compositions include a fusion protein comprising: (a) a...
2017/0233447 PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF
The present invention relates to the field of biopharmaceuticals, and in particular to a protein, a protein conjugate, a pharmaceutical composition and its use...
2017/0233446 METHODS AND COMPOSITIONS USING KLOTHO-FGF FUSION POLYPEPTIDES
The present invention is directed to methods, kits and compositions for preventing or treating age-related conditions or metabolic disorders. The Klotho fusion...
2017/0233445 ANTI-MICROBIAL PEPTIDE AND METHOD FOR TREATING MICROBIAL INFECTION
The present invention provides an antimicrobial peptide, wherein the antimicrobial peptide comprises SEQ ID NO: 4.
2017/0233444 RTEF-1 VARIANTS AND USES THEREOF
Disclosed are variant RTEF-1 polypeptides having an RTEF-1 amino acid sequence with one or more internal deletions, wherein the polypeptides reduce VEGF...
2017/0233443 CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE
The invention provides a cyclic polypeptide of Formula I (SEQ ID NO: 1): X1-R-X3-X4-L-S-X7-X8-X9-X10-X11-X12-X13 I or an amide, an ester or a salt thereof, or...
2017/0233442 PEPTIDYLYIC INHIBITOR TARGETING CAG-REPEAT RNA TOXICITY IN POLYGLUTAMINE DISEASES
The present invention provides for a novel peptide and method for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for...
2017/0233441 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE
HIV-1 Env ectodomain trimers stabilized in a prefusion mature closed conformation and methods of their use and production are disclosed. In several...
2017/0233440 INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE
Compositions and methods for controlling pests are provided. The methods involve transforming organisms with a nucleic acid sequence encoding an insecticidal...
2017/0233439 INSECTICIDAL POLYPEPTIDES HAVING BROAD SPECTRUM ACTIVITY AND USES THEREOF
The invention provides nucleic acids, and variants and fragments thereof, obtained from strains of Bacillus thuringiensis encoding polypeptides having...
2017/0233438 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS
The present invention provides cyclic depsipeptide compounds of formula (I) and compositions comprising the compounds that are effective against parasites that...
2017/0233437 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII
The present invention provides compounds of formula (I) ##STR00001## wherein X.sup.1 to X.sup.8 and R.sup.1 to R.sup.8 are as described herein, as well as...
2017/0233436 BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING
Benzodiazepine dimers having a structure represented by ##STR00001## wherein R.sup.1 is ##STR00002## wherein the variables in formulae (I), (Ia), and (Ib) are as...
2017/0233435 A METHOD FOR MOLECULAR EXTRACTION IN LIVE CELLS
A method of extracting biomolecules from live cells comprising: introducing a plurality of magnetized carbon nanotubes (MCNTs) into a live cell, wherein the...
2017/0233433 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof; wherein, R.sup.1, R.sup.2a, R.sup.2b, R.sup.3 and...
2017/0233432 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF
Provided herein are 3,3-disubstituted 19-nor-steroidal compounds according to Formula (I): ##STR00001## and pharmaceutical compositions thereof. Such compounds...
2017/0233431 BILE ACID DERIVATIVES AND METHODS FOR SYNTHESIS AND USE
Provided herein, inter alia, are methods for the preparation of modulators of farnesoid X receptor (FXR), and compositions and uses of the modulators of FXR.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.